|
TOX4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.98578955898665E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.7610136399403E-12 |
| Normal-vs-Stage2 |
9.99179999849886E-08 |
| Normal-vs-Stage3 |
5.59589999999943E-05 |
| Normal-vs-Stage4 |
3.32050000051431E-07 |
| Stage1-vs-Stage2 |
9.543600E-01 |
| Stage1-vs-Stage3 |
3.817600E-01 |
| Stage1-vs-Stage4 |
4.286800E-01 |
| Stage2-vs-Stage3 |
5.281800E-01 |
| Stage2-vs-Stage4 |
3.889200E-01 |
| Stage3-vs-Stage4 |
2.242400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.837041795407E-12 |
| Normal-vs-AfricanAmerican |
4.98100005685842E-10 |
| Normal-vs-Asian |
5.616200E-04 |
| Caucasian-vs-AfricanAmerican |
8.988000E-01 |
| Caucasian-vs-Asian |
9.500800E-01 |
| AfricanAmerican-vs-Asian |
9.103600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.20743431814208E-13 |
| Normal-vs-Female |
2.46829999994702E-06 |
| Male-vs-Female |
3.476100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.06430000263092E-08 |
| Normal-vs-Extreme_Weight |
1.32782673745169E-13 |
| Normal-vs-Obese |
2.41179999971308E-07 |
| Normal-vs-Extreme_Obese |
6.16080000015451E-07 |
| Normal_Weight-vs-Extreme_Weight |
5.388600E-01 |
| Normal_Weight-vs-Obese |
2.226800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.157800E-01 |
| Extreme_Weight-vs-Obese |
2.595900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.207200E-01 |
| Obese-vs-Extreme_Obese |
2.024000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.241600E-02 |
| Normal-vs-Age(41-60Yrs) |
4.20489976171723E-10 |
| Normal-vs-Age(61-80Yrs) |
1.71285208239169E-12 |
| Normal-vs-Age(81-100Yrs) |
3.84380000051365E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.892600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.989380E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.207220E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.940200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.326360E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.661600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.18935980456081E-12 |
| Normal-VS-Type2 PRCC |
2.30220287278371E-11 |
| Normal-VS-KIRP CIMP |
2.789400E-01 |
| Normal-VS-Unclassified PRCC |
3.62489999999882E-05 |
| Type1 PRCC-VS-Type2 PRCC |
9.098200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.646000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.340400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.580000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.843800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.372200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.12256903562047E-13 |
| Normal-vs-N1 |
1.778160E-02 |
| Normal-vs-N2 |
1.62510000012439E-07 |
| N0-vs-N1 |
3.057600E-02 |
| N0-vs-N2 |
1.286170E-01 |
| N1-vs-N2 |
6.891600E-02 |
|
|
